首页 | 本学科首页   官方微博 | 高级检索  
     

国产与进口硝呋太尔-制霉菌素阴道栓随机双盲对照治疗念珠菌阴道炎
引用本文:董晓静,胡丽娜,唐莨萏,常青. 国产与进口硝呋太尔-制霉菌素阴道栓随机双盲对照治疗念珠菌阴道炎[J]. 中国临床药理学杂志, 2004, 20(5): 341-344
作者姓名:董晓静  胡丽娜  唐莨萏  常青
作者单位:1. 重庆医科大学,附属第二医院妇产科,重庆,400010
2. 重庆医科大学附属第二医院妇产科,重庆,400010
3. 重庆医科大学,附属第一医院,妇产科,重庆,400016
4. 第三军医大学,西南医院,妇产科,重庆,400040
摘    要:目的评价硝呋太尔-制霉菌素阴道栓治疗念珠菌阴道炎的疗效和安全性。方法 用随机双盲对照试验,试验组67例,对照组69例,分别给予国产和进口硝呋太尔-制霉菌素阴道栓,治疗6日。分别于停药后第1天和停药后月经来潮干净3~7天,观察外阴阴道瘙痒、白带和体征变化,同时进行阴道分泌物病原学检查。结果 停药后第1天,试验组和对照组的临床治愈率分别为92.54%和91.30%,有效率分别为97.01%和95.65%,病原学清除率分别为97.01%和95.65%;停药后月经来潮干净后3~7天,临床治愈率分别为70.15%和 68.12%,有效率分别为73.13%和72.46%,病原学清除率分别为73.13%和72.46%。经统计学处理,2组疗效无显著差异(P>0.05)。试验中未见明显药物不良反应。结论 硝呋太尔-制霉菌素阴道栓治疗念珠菌阴道炎安全、有效。

关 键 词:硝呋太尔-制霉菌素阴道栓  念珠菌阴道炎
文章编号:1001-6821(2004)05-0341-04

Double-blind randomized controlled clinical trial on domestic versus imported nifuratel-nysfungin suppository in the treatment of vulvovaginal candidiasis
DONG Xiao-jing,HU Li-na,TANG Liang-dan,CHANG Qing. Double-blind randomized controlled clinical trial on domestic versus imported nifuratel-nysfungin suppository in the treatment of vulvovaginal candidiasis[J]. The Chinese Journal of Clinical Pharmacology, 2004, 20(5): 341-344
Authors:DONG Xiao-jing  HU Li-na  TANG Liang-dan  CHANG Qing
Affiliation:DONG Xiao-jing1,HU Li-na1,TANG Liang-dan2,CHANG Qing3
Abstract:Objective To evaluate efficacy and safety of domestic and importednifuratel-nysfungin suppository in the treatment of vulvovaginal candidiasis.Methods A double-blind randomized controlled clinical trail was conducted. Sixtyseven cases in test group and 69 cases in control group were given domestic andimported nifuratel-nysfungin suppository for 6 days. Vulvovaginal pruritus,leucorrhea, signs as well as pathogens were observed respectively 1 day aftertreatment and 3~7 days after menorrhea. Results After 6-days treatment, the curerates were 92.54% in test group, and 91.30% in control group; the efficacy rates were97.01% and 95.65%, the eradicated rates of pathogen were 97.01% and 95.65% ,respectively. Three to seven days after menorrhea, the cure rates were 70.15% intest group, and 68.12% in control group, the efficacy rates were 73.13% and 72.46%,the eradicated rates of pathogen were 73.13% and 72.46%, respectively. There wasno significant statistic difference between these two groups in efficacy and safety(P>0.05). Conclusion Nifuratel-nysfungin suppository is an effective and safepreparation in the treatment of vulvovaginal candidasis.
Keywords:nifuratel-nysfungin suppository  vulvovaginal candidiasis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号